AAA
Affinity Asset Advisors Portfolio holdings
AUM
$1.39B
1-Year Est. Return
230.19%
This Fund
S&P 500
1 Year Est. Return
+230.19%
AUM
$1.07B
AUM Growth
+$399M
(+59%)
Holding
110
Top Buys
| 1 | +$54.2M | |
| 2 | +$18.4M | |
| 3 | +$15.9M | |
| 4 |
Soleno Therapeutics
SLNO
|
+$14.8M |
| 5 |
Cytokinetics
CYTK
|
+$14.4M |
Top Sells
| 1 | +$32M | |
| 2 | +$12.5M | |
| 3 | +$8.84M | |
| 4 |
INZY
Inozyme Pharma
INZY
|
+$7M |
| 5 |
Vera Therapeutics
VERA
|
+$5.59M |
Sector Composition
| 1 | Healthcare | 91.07% |
| 2 | Financials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Summit Therapeutics
SMMT
$11.4B
| – | – |
0
|
|
||
|
THRD
102
DELISTED
Third Harmonic Bio
THRD
| – | – |
-370,000
|
|
||
|
ATYR
103
aTyr Pharma
ATYR
$92.7M
| – | – |
0
|
|
||
|
RAPP
104
Rapport Therapeutics
RAPP
$1.33B
| – | – |
-199,643
|
|
||
|
OKUR
105
OnKure Therapeutics
OKUR
$40.1M
| – | – |
-347,990
|
|
||
|
RADX
106
Radiopharm Theranostics
RADX
$37.4M
| – | – |
-35,635
|
|